Management of von Willebrand disease type 3 during pregnancy - 2 cases reports.

Inocêncio, G.; Braga, A.; Azevedo, S.; Buchner, C

http://hdl.handle.net/10400.16/1684

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Management of von Willebrand disease type 3.pdf		79.18 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

BACKGROUND: von Willebrand disease type 3, is an extremely rare condition. It can be severe and potentially life-threatening, particularly in pregnant women during labor and subsequently during early puerperium. Due to its rarity, there is no optimal treatment/management during pregnancy. CASE: We describe two cases of pregnant women with von Willebrand disease type 3, and its successful surveillance and treatment with Haemate P FVIII (human plasma-derived von Willebrand Factor-ristocetin co-factor associated with human coagulation factor VIII), during pregnancy, partum and puerperium. CONCLUSIONS: Daily prophylaxis with Haemate P FVIII in women with von Willebrand disease type 3, starting 2 hours before caesarean section until the 7th day of puerperium, associated with close analytical and clinical surveillance seems to be a safe clinical option.